Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sildenafil citrate (Viagra).

A M MacConnachie

    Intensive & Critical Care Nursing
    |December 14, 1999
    PubMed
    Summary

    Sildenafil, an oral treatment for erectile dysfunction (ED), shows variable efficacy, with success rates around 70% decreasing in high-risk groups. Cost and prescription policies are debated, impacting NHS access for men with hypertension.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Zanamivir (Relenza )--a new treatment for influenza.

    Intensive & critical care nursing·2002
    Same author

    Palivizumab (Synagis) for prevention of respiratory illness in children.

    Intensive & critical care nursing·2002
    Same author

    Bupropion (Zyban) for smoking cessation.

    Intensive & critical care nursing·2000
    Same author

    Rofecoxib (Vioxx)--the first of a new generation of NSAIDs.

    Intensive & critical care nursing·2000
    Same author

    Orlistat (Xenical).

    Intensive & critical care nursing·2000
    Same author

    Temozolomide (Temodal) for treatment of primary brain tumours.

    Intensive & critical care nursing·2000

    Area of Science:

    • Urology
    • Pharmacology

    Background:

    • Erectile dysfunction (ED) affects numerous men, particularly those with hypertension and small vessel disease.
    • Sildenafil represents a novel oral therapy for ED, leading to significant demand and cost implications for healthcare systems like the NHS.
    • The introduction of oral ED treatments necessitates a review of clinical and political considerations regarding accessibility and cost-effectiveness.

    Purpose of the Study:

    • To evaluate the efficacy of sildenafil in treating ED.
    • To discuss the clinical and economic implications of widespread sildenafil use.
    • To explore policy options for managing the cost and accessibility of sildenafil prescriptions.

    Main Methods:

    • Clinical trial data analysis on sildenafil's efficacy in achieving intercourse-sufficient erections.
    • Review of patient demographics, including 'high-risk' groups such as diabetics.
    • Examination of placebo response rates in clinical trials.

    Main Results:

    • Sildenafil achieved successful erections in approximately 70% of occasions in clinical trials.
    • Efficacy decreased to 50% in high-risk populations like diabetics.
    • Placebo response rates ranged from 10% to 20%.

    Conclusions:

    • Sildenafil is an effective oral treatment for ED, but its success varies across patient groups.
    • The cost and appropriate prescription criteria for sildenafil remain subjects of ongoing debate.
    • Policy decisions, such as restricting sildenafil to private prescriptions, are being considered to manage healthcare costs and prevent misuse.

    Related Experiment Videos